Publication Name	World Journal of Clinical Oncology
Manuscript ID	65224
Country	Spain

Received	2021-03-01 21:02
Peer-Review Started	2021-03-01 21:06
To Make the First Decision
Return for Revision	2021-09-02 02:10
Revised	2021-09-19 22:50
Second Decision	2022-01-17 05:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-01-20 05:33
Articles in Press	2022-01-20 05:33
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-02-16 13:51
Publish the Manuscript Online	2022-02-23 09:24

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Management of genitourinary syndrome of menopause in breast cancer survivors: An update
Manuscript Source	Invited Manuscript
All Author List	Daniel María Lubián López
ORCID	Author(s) ORCID Number Daniel María Lubián López http://orcid.org/0000-0001-8861-1751
Funding Agency and Grant Number
Corresponding Author	Daniel María Lubián López, MD, PhD, Full Professor, Department of Mother and Child Health and Radiology, Faculty of Medicine.University of Cadiz, Service of Obstetrics and Gynecology, University Hospital of Puerto Real, Cádiz, Spain 11510. dmlulo@gmail.com, Cádiz 11100, Cádiz, Spain. dmlulo@gmail.com
Key Words	Genitourinary syndrome of menopause; Breast cancer survivors; Aromatase inhibitors; Vaginal moisturizers and lubricants; Vaginal estrogens; Laser
Core Tip	Genitourinary syndrome of menopause (GSM) is commonly experienced by breast cancer survivors (BCSs) receiving antiestrogen therapy, specifically aromatase inhibitors. Vaginal dryness, itching, irritation and dyspareunia produce impairment of sexual function and negatively impact on the quality of life. Healthy women, and even more so BCSs, are reluctant to discuss this problem with their general practitioner or oncologist. Safety of vaginal estrogen therapy for management of GSM refractory to other nonhormonal treatment in BCSs has not been definitively established, and recommendations for use remain controversial. This review aims to summarize the clinical approach and emerging therapeutic alternatives, considering the efficacy and potencial adverse effects in this population.
Publish Date	2022-02-23 09:24
Citation	Lubián López DM. Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World J Clin Oncol 2022; 13(2): 71-100
URL	https://www.wjgnet.com/2218-4333/full/v13/i2/71.htm
DOI	https://dx.doi.org/10.5306/wjco.v13.i2.71

Full Article (PDF)	WJCO-13-71.pdf
Full Article (Word)	WJCO-13-71.docx
Manuscript File	65224_Auto_Edited.docx
Answering Reviewers	65224-Answering reviewers.pdf
Audio Core Tip	65224-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	65224-Conflict-of-interest statement.pdf
Copyright License Agreement	65224-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65224-Language certificate.pdf
Peer-review Report	65224-Peer-review(s).pdf
Scientific Misconduct Check	65224-Bing-Wang LL-2.png
Scientific Editor Work List	65224-Scientific editor work list.pdf
CrossCheck Report	65224-CrossCheck report.pdf